NewYork Presbyterian / Weill Cornell
Locations
Transplant Summary
Overview
The Transplant Program at NewYork-Presbyterian Hospital Weill Cornell utilizes state-of-the-art technologies to provide comprehensive bone marrow and stem cell transplantation care. Thanks to its extensive array of medical specialties and services, the program uniquely cares for complex, and often older patients. Bone marrow and stem cell transplantation care and treatment are available.This center has been performing allogeneic transplants since 1999 and has been an NMDP transplant center since March 2002.
Attending physicians
Adult - Amer Assal, Juliet Barker, Nora Chokr, Alexandra Gomez, Sebastian Mayer, Roger Pearse, Tsiporah ShoreTransplants performed
Marrow/PBSC, single cord, and double cordCord blood transplants
Adult onlyOther programs and services
The program is fully integrated into NewYork- Presbyterian Weill Cornell, the largest and most reputable hospital in New York City, routinely listed among the top hospitals in the US. This provides access to multiple specialists and services for complex patients.
Special arrangements for lodging are across the street from the center and available for patients from remote distances. The inpatient rehabilitation unit provides opportunity for recovery for older and more infirm patients.Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 194 patients.The actual 1-year survival of these patients is 71.1%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 65% and 76.9%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
247
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow1PBSC31Cord blood0Total32Unrelated donorMarrow1PBSC82Cord blood38Total121Total allogeneicMarrow2PBSC113Cord blood38Total153AutologousMarrowBoth marrow & PBSC 94PBSC—Cord blood—Total94Total combinedMarrowBoth marrow & PBSC 209PBSC—Cord blood38Total247All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-18019-441145-641365+8Total32Unrelated 0-18019-442945-645065+42Total121Autologous 0-18019-441445-644965+31Total94Total 0-18019-445445-6411265+81Total247Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
Weill Cornell NYP
520 East 70th street New York, NY 10021 Phone:646-962-7950 For more information about this program: https://cornellbmt.org (Opens in a new tab)Overview
Long-term survivors are assigned to a transplant physician and Nurse Practitioner. They are assisted in the care of the patients by a multidisciplinary team including pulmonologist, infectious disease specialists, social workers.
Staff
Program Director:Tsiporah Shore, MD. FRCPC, FACPProgram Coordinator:Janel Joaquin, RNMedical Specialties in Program
Cardiology, dentistry, dermatology, gastroenterology, gynecology, hematology, infectious disease, nephrology, neurology, oncology, ophthalmology/optometry, orthopedics, otolaryngology, palliative care, psychiatry/psychology, pulmonology, rheumatology.Medical Services Offered
Chronic GVHD management, fertility counseling, reproductive health, financial counseling, nutrition/dietetics, occupational therapy, physical therapy and rehabilitation, sexual health, social services, vaccinations.Telemedicine services are available.Patient Eligibility
Adults- Allogeneic and Autologous transplant recipients
- Adults: 24 after transplant.
- Adults (over age 18)
- Will provide care to adult patients who underwent transplant as a child
- Does accept patients who were transplanted at another hospital